It seems we can’t find what you’re looking for. Perhaps searching can help.
- 3516
[] Institution:Timothy Yap – [3516] Trial:A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) plus Venetoclax and Rituximab versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-322)